Review Series: February 14, 2019

Advances in Multiple Myeloma

Introduced by Hervé Avet-Loiseau, this review series on advances in multiple myeloma deals with clinically timely questions. What is the optimal imaging approach at diagnosis and follow-up? Is frontline high-dose melphalan with stem cell support still the standard of care? With so many novel drugs, are we ready for patient-adjusted treatment?


Listen as Drs. Hervé Avet-Loiseau, Shaji Kumar, and Faith Davies discuss highlights of this review series.